Lucas Ward
Stock Analyst at Ascendiant Capital
(0.75)
# 4,217
Out of 5,182 analysts
31
Total ratings
32.26%
Success rate
-32.07%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $5.5 → $3 | $0.86 | +247.58% | 6 | Apr 22, 2026 | |
| SXTP 60 Degrees Pharmaceuticals | Maintains: Buy | $11 → $4.2 | $1.62 | +159.26% | 5 | Apr 9, 2026 | |
| ACON Aclarion | Maintains: Buy | $23 → $7 | $3.37 | +107.72% | 6 | Mar 25, 2026 | |
| HSCS HeartSciences | Maintains: Buy | $9.2 → $8 | $2.01 | +298.01% | 5 | Mar 24, 2026 | |
| LIQT LiqTech International | Maintains: Buy | $4.2 → $4.3 | $2.17 | +98.16% | 7 | Mar 10, 2026 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $135,000 → $108,000 | $1.20 | +8,999,900.00% | 2 | Jul 29, 2024 |
Vivos Therapeutics
Apr 22, 2026
Maintains: Buy
Price Target: $5.5 → $3
Current: $0.86
Upside: +247.58%
60 Degrees Pharmaceuticals
Apr 9, 2026
Maintains: Buy
Price Target: $11 → $4.2
Current: $1.62
Upside: +159.26%
Aclarion
Mar 25, 2026
Maintains: Buy
Price Target: $23 → $7
Current: $3.37
Upside: +107.72%
HeartSciences
Mar 24, 2026
Maintains: Buy
Price Target: $9.2 → $8
Current: $2.01
Upside: +298.01%
LiqTech International
Mar 10, 2026
Maintains: Buy
Price Target: $4.2 → $4.3
Current: $2.17
Upside: +98.16%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $135,000 → $108,000
Current: $1.20
Upside: +8,999,900.00%